NCT06788509 2025-10-10A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringJanssen Research & Development, LLCPhase 1 Enrolling by invitation80 enrolled
NCT04210219 2025-08-21A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic LeukemiaJanssen Research & Development, LLCPhase 1 Completed85 enrolled